Meelis Lootus


Member of IEEE Novel Biomarkers for Decentralised Clinical Trials Working Group - IEEE



Meelis is the CEO & founder of Tehistark, working with biotechnology and pharmaceutical companies to accelerate clinical trial and regulatory workflows with AI. He was previously director of AI engineering at Sharecare Inc (core team at doc.ai, acquired by Sharecare), where he led teams to deploy cutting edge AI models in production. His team’s focus was on digital biomarkers. He is an expert on clinical trial innovation and sits on the IEEE committee on decentralised clinical trial design and digital biomarkers, where he led development of guidelines and recommendations. He has a PhD in AI applied to digital health from Oxford University, autimating the interpretation of MRI scans



Meelis Lootus

Sessions


  • Wednesday - May 29, 2024 - 16:15

    Interpretation and Impact of Real-World Clinical Data

    • Strategies for better decision-making
    • High-level models and simulations compelled by data will allow elimination of risky trials
    • The potential of real world data in clinical research goes past patient identification and patient recruitment


  • Wednesday - May 29, 2024 - 16:45

    Panel Discussion: Leveraging Big Data and AI in the Era of Tech-Driven Clinical Trials: Opportunities and Ethical Dilemmas


 

Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now